About Healthcare News
Novo CEO pressed by Senate to cut selling prices of being overweight, diabetes medication CEO Lars Fruergaard Jørgensen informed lawmakers the company would take into consideration new talks with insurers regarding the record rates of Wegovy and copyright should they pledge to help keep the medicines on their own formularies.Sanders swiftly condem